Annual Retained Earnings
-$274.52 M
-$35.04 M-14.63%
31 December 2022
Summary:
Zynerba Pharmaceuticals annual retained earnings is currently -$274.52 million, with the most recent change of -$35.04 million (-14.63%) on 31 December 2022. During the last 3 years, it has fallen by -$72.34 million (-35.78%).ZYNE Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$295.41 M
-$10.78 M-3.79%
30 June 2023
Summary:
Zynerba Pharmaceuticals quarterly retained earnings is currently -$295.41 million, with the most recent change of -$10.78 million (-3.79%) on 30 June 2023.ZYNE Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZYNE Retained Earnings Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | -35.8% | -28.1% |
5 y5 years | -132.8% | -110.8% |
ZYNE Retained Earnings High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | ||||
5 y | 5 years | ||||
alltime | all time | +6197.6% | +2845.6% |
Zynerba Pharmaceuticals Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
June 2023 | - | -$295.41 M(+3.8%) |
Mar 2023 | - | -$284.63 M(+3.7%) |
Dec 2022 | -$274.52 M(+14.6%) | -$274.52 M(+3.0%) |
Sept 2022 | - | -$266.50 M(+3.4%) |
June 2022 | - | -$257.83 M(+4.0%) |
Mar 2022 | - | -$247.97 M(+3.5%) |
Dec 2021 | -$239.48 M(+18.5%) | -$239.48 M(+3.8%) |
Sept 2021 | - | -$230.67 M(+4.8%) |
June 2021 | - | -$220.08 M(+4.7%) |
Mar 2021 | - | -$210.13 M(+3.9%) |
Dec 2020 | -$202.17 M(+34.0%) | -$202.17 M(+5.0%) |
Sept 2020 | - | -$192.55 M(+4.9%) |
June 2020 | - | -$183.51 M(+12.5%) |
Mar 2020 | - | -$163.17 M(+8.2%) |
Dec 2019 | -$150.84 M(+27.9%) | -$150.84 M(+7.6%) |
Sept 2019 | - | -$140.12 M(+1.4%) |
June 2019 | - | -$138.17 M(+8.8%) |
Mar 2019 | - | -$127.04 M(+7.8%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2018 | -$117.89 M(+51.2%) | -$117.89 M(+7.1%) |
Sept 2018 | - | -$110.10 M(+7.6%) |
June 2018 | - | -$102.29 M(+13.3%) |
Mar 2018 | - | -$90.29 M(+15.8%) |
Dec 2017 | -$77.98 M(+69.6%) | -$77.98 M(+11.6%) |
Sept 2017 | - | -$69.86 M(+13.5%) |
June 2017 | - | -$61.55 M(+15.6%) |
Mar 2017 | - | -$53.23 M(+15.8%) |
Dec 2016 | -$45.97 M(+103.6%) | -$45.97 M(+17.7%) |
Sept 2016 | - | -$39.07 M(+18.1%) |
June 2016 | - | -$33.09 M(+23.2%) |
Mar 2016 | - | -$26.86 M(+19.0%) |
Dec 2015 | -$22.58 M(+125.2%) | -$22.58 M(+31.7%) |
Sept 2015 | - | -$17.14 M(+30.4%) |
June 2015 | - | -$13.15 M(+14.1%) |
Mar 2015 | - | -$11.52 M(+14.9%) |
Dec 2014 | -$10.03 M(+130.1%) | -$10.03 M |
Dec 2013 | -$4.36 M | - |
FAQ
- What is Zynerba Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Zynerba Pharmaceuticals?
- What is Zynerba Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Zynerba Pharmaceuticals?
What is Zynerba Pharmaceuticals annual retained earnings?
The current annual retained earnings of ZYNE is -$274.52 M
What is the all time high annual retained earnings for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high annual retained earnings is -$4.36 M
What is Zynerba Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of ZYNE is -$295.41 M
What is the all time high quarterly retained earnings for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high quarterly retained earnings is -$10.03 M